Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2

Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2

Objectives Angiogenesis occurs during tumor progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). Arsenic trioxide (ATO) shows promising therapeutic potential in advanced HCC. Whether ATO regulates angiogenesis and can be used to prevent tumor progression in...

Full description

Bibliographic Details
Main Authors: Shuying Dong, Zhuxin Li, Jian Kong, Shilun Wu, Jun Gao, Wenbing Sun
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:International Journal of Hyperthermia
Subjects:
Hepatocellular carcinoma
radiofrequency ablation
arsenic trioxide
angiogenesis
angiopoietin
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2022.2093995

Internet

https://www.tandfonline.com/doi/10.1080/02656736.2022.2093995

Similar Items